3-(5-Fluoro-2-methylphenyl)-2-methyl-1-propene, 97.0%, 1g

1H,4H,5H,6H,7H,8H-cyclohepta[c]pyrazol-4-one, 97%, 1g

(4S,5S)-1,3-Bis(2-(methoxymethyl)phenyl)-4,5-diphenyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate, 98%, 100mg

3'-Fluoro-4-iodo-5'-methylbenzophenone, 97.0%, 1g

2,4,6-Trifluorobenzyl alcohol, 97.0%, 25g

Benzoic acid, 4-[[[(8-chloro-1,4-dihydro-1-methyl[1]benzopyrano[4,3-c]pyrazol-3-yl)carbonyl](phenylmethyl)amino]methyl]-, 10mg

(2-Cyclobutylethyl)amine, 95.0%, 1g

4-FLUORO-N-METHYL-3-NITROBENZAMIDE, 95.0%, 10g

N-(5-Amino-2-fluorophenyl)acetamide, 95.0%, 5g

5-(difluoromethyl)-1,3,4-thiadiazol-2-amine, 95+%, 5g

Benzo[d]oxazol-2-ylmethanol, 95.0%, 1g

GC capillary column ROTI®Cap-FFAP, 25 m, 0.32 mm, 0.50 µm, 1 Piece(s)

Benzonitrile, 4-[5-[(1E)-2-[4-(2-chlorophenyl)-5-[5-(methylsulfonyl)-2-pyridinyl]-4H-1,2,4-triazol-3-yl]ethenyl]-1,3,4-oxadiazol-2-yl]-, 5mg